AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,104 | -48.7% | 18,745 | -63.1% | 0.00% | – |
| Q2 2023 | $154,250 | +97.3% | 50,805 | -9.7% | 0.00% | – |
| Q1 2023 | $78,186 | -29.6% | 56,250 | +1.5% | 0.00% | – |
| Q4 2022 | $111,000 | -5.9% | 55,399 | -5.3% | 0.00% | – |
| Q3 2022 | $118,000 | -38.5% | 58,490 | +0.0% | 0.00% | – |
| Q2 2022 | $192,000 | +51.2% | 58,487 | -0.0% | 0.00% | – |
| Q1 2022 | $127,000 | -55.0% | 58,489 | +0.2% | 0.00% | -100.0% |
| Q4 2021 | $282,000 | -8.7% | 58,355 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $309,000 | +9.2% | 56,356 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $283,000 | +1.1% | 53,994 | +27.5% | 0.00% | 0.0% |
| Q1 2021 | $280,000 | +67.7% | 42,357 | +16.0% | 0.00% | – |
| Q4 2020 | $167,000 | -25.1% | 36,521 | -24.3% | 0.00% | -100.0% |
| Q3 2020 | $223,000 | -2.2% | 48,223 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $228,000 | +68.9% | 48,082 | +13.4% | 0.00% | 0.0% |
| Q1 2020 | $135,000 | – | 42,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |